T
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K312.0 KBTurning Point Therapeutics, Inc.Aug 17, 8:44 AM ET·0001140361-22-029961
- 8-K420.1 KBTurning Point Therapeutics, Inc.Aug 8, 4:18 PM ET·0000950170-22-015547
- 10-Q10.5 MBTurning Point Therapeutics, Inc.Aug 8, 4:17 PM ET·0000950170-22-015542
- 8-K147.9 KBTurning Point Therapeutics, Inc.Jun 24, 9:01 AM ET·0001193125-22-180854
- 8-K153.0 KBTurning Point Therapeutics, Inc.Jun 21, 4:01 PM ET·0001193125-22-177616
- 8-K827.8 KBTurning Point Therapeutics, Inc.Jun 3, 5:15 PM ET·0001193125-22-167430
- 8-K204.9 KBTurning Point Therapeutics, Inc.Jun 3, 9:00 AM ET·0001193125-22-166796
- 10-Q8.1 MBTurning Point Therapeutics, Inc.May 10, 4:10 PM ET·0000950170-22-008971
- 8-K5.3 MBTurning Point Therapeutics, Inc.May 10, 4:09 PM ET·0000950170-22-008970
- 8-K170.3 KBTurning Point Therapeutics, Inc.May 5, 9:01 AM ET·0000950170-22-007585
Insiders
10- Alles Mark JDirector
- Baker Brian LeeVP of Finance and Admin.
- Bodem Barbara W.Director
- Chacko JacobDirector
- Chen BihuaDirector, 10% Owner
- Cormorant Asset Management, LPFormer 10% Owner
- Countouriotis AthenaDirector, President & CEO
- Cui Jingrong JeanDirector, Chief Scientific Officer
- Gallagher Carol GiltnerDirector
- George SimeonDirector
Tickers
No tickers on record
Addresses
business
10628 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO, CA, 92121
mailing
10628 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO, CA, 92121
Former Names
- TP Therapeutics, Inc.2018-10-30
- TP Therapeutics, INC2017-05-25